RE:RE:IVIG STORY - FDA grants seven years of marketing exclusiviWhile they were still doing phase 3 equivalency trials on IVIG for a slam dunk bunch of extra revenue producing a 2nd protein from Ryplazim production, mgmt decided to write down the ivig piece of business value to zero to financially engineer the recapitalization in April 2019. So, it is an important piece of the story of the theft of PLI from retail shareholders. Thomvest had full control over management and they couldn't fight or risk losing their lucrative salaries. Hope they all pay in the end.
wyndewest wrote: Stockman, the IVIG story you posted this morning is very interesting. Already there have been over 130 reads. You seem to have pushed a 'hot button'. Is this the same IVIG that Prometice was developing or has this been developed by a third party? There are so many facets to the Prometic/Liminal story I have forgotten what happened with the IVIG developed by Prometic. Thanks.